Close menu

January 13th, 2022 | 12:01 CET

Stocks offer trading opportunities: BrainChip, TeamViewer, XPhyto

  • Trading
Photo credits:

On Thursday, most German indices started trading with negative signs. The DAX is currently trading at 15,989 points, down around 0.25%. The psychological mark of 16,000 points has not held compared to the previous day. The MDAX last traded at 34,874 points (-0.14%), TecDAX at 3,637 points (-0.62%) and SDAX at 16,062 points with 0.13% in the red. In the single stocks, on the other hand, there are exciting developments for the stock traders.

time to read: 1 minutes | Author: Mario Hose

Table of contents:

    Does chip shortage cause hype?

    BrainChip's stock is among the companies with the most executed orders on Tradegate in the first hours of trading. The chip developer's stock is up 18.54% at EUR 0.9305. In total, more than 1.6 million shares of the company have already been traded. Since it became known that Mercedes-Benz relies on BrainChip's technology, interest in the company on stock exchanges has increased significantly. More information is expected from the company at the International Investment Forum (IIF), on Feb. 17, 2022 (Free to attend:

    Get in on Turnaround Stories now?

    TeamViewer currently leads the MDAX companies with the most executed orders. A total of 650 trades have been counted so far. At EUR 13.34, the share is slightly down by 0.41%. In the first quarter of the previous year, the shares were changing hands at over EUR 45.00.

    A positive company development has published XPhyto Therapeutics in the morning. The company has signed a distribution agreement for numerous European countries. The content is the sale of rapid PCR tests (Covid-ID Lab), which already provide a result within 20 minutes. Prof. Dr. Thomas Beckert heads XPhyto's diagnostics and drug formulation business and signals further growth: "This is an important relationship with excellent potential for additional territorial expansion."

    Demand for testing appears unabated. As Reuters reports today, the U.S. government plans to increase Covid-19 testing capacity for schools by 10 million per month. XPhyto shares were trading above EUR 2.00 about a year ago and are currently trading at around EUR 0.80.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author

    Related comments:

    Commented by Mario Hose on January 11th, 2022 | 11:36 CET

    Trading stocks in focus: BioNTech, Darktrace, EXMceuticals

    • Trading

    Tuesday is under a good omen on the stock market after a failed start to the week. Germany's leading index, the DAX, is trading at 15,961 points, up around 0.32%, but has not yet made it above the psychological 16,000 mark. The MDAX last traded at 34,713 points (+0.42%), TexDAX at 3,661 points (+1.09%) and SDAX at 15,913 points with 0.66% in the plus.


    Commented by Mario Hose on January 10th, 2022 | 12:02 CET

    Trading stocks in focus: Aspermont, BASF, BioNTech

    • Trading

    At the beginning of the week, the DAX is currently trading around 0.19% down at 15,939 points and thus remains below the psychological mark of 16,000 points. The MDAX recently traded again below the 35,000 mark at 34,804 points (-0.52%), TexDAX at 3,653 points (-1.50%) and SDAX at 15,936 points with 1.06% in the red. Overall, the indices had given back their initial gains from the start of trading and are trading in negative territory in the morning.


    Commented by Mario Hose on January 7th, 2022 | 16:04 CET

    Trading shares in focus: Allianz, BioNTech, BrainChip

    • Trading

    At the end of the week, the DAX was down around 0.37% at 15,968 points and thus below the psychological mark of 16,000 points. The MDAX last traded at 35,002 points (-34%), TexDAX at 3,731 points (-0.36%) and SDAX at 16,125 points with 0.92% in the red.